Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome


      Purpose: Metabolic Syndrome as defined by ATP III criteria, a constellation of risk factors associated with insulin resistance, predisposes to premature atherosclerosis and early coronary events. Whether that negative risk profile is associated with endothelial dysfunction remains to be established. Materials and methods: Transcapillary escape rate of albumin (TERalb), a measure of capillary permeability and integrity of systemic capillary endothelium, and forearm vasodilation to intra-arterial acetylcholine (ACH), an index of nitric oxide (NO)-mediated vasomotor dysfunction, were assessed in 24 non-diabetic, uncomplicated hypertensive men with Metabolic Syndrome according to ATP III criteria (hypertension with at least two additional traits such as high triglycerides, low HDL, abdominal obesity, impaired fasting or post-load plasma glucose). Twelve age-matched lean normal hypertensive patients with normal lipid and glucose profile and nine normotensive subjects were the controls. All patients underwent lipids determination and fasting and post-OGTT insulin assessment; HOMA-IR was the index of insulin resistance. Results: TERalb was higher in hypertensive patients with Metabolic Syndrome, without differences between hypertensive and normotensive controls. Blood pressure (BP), lipids, plasma glucose, insulin levels and HOMA-IR were unrelated to TERalb. Responses to acetylcholine were selectively attenuated in metabolic patients and, on an individual basis, related only to HDL cholesterol levels, independent of LDL cholesterol, BP, body size, triglycerides, and HOMA-IR values. No relationship existed between responses to acetylcholine and TERalb. Conclusions: Altered systemic capillary permeability characterizes insulin-resistant hypertensive patients with Metabolic Syndrome. That defect, which may promote early atherosclerosis development, coexists with blunted endothelial-mediated vasodilation, indicating a pervasive abnormality of endothelial function.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lakka H.M.
        • Laaksonen D.E.
        • Lakka T.A.
        • Niskanen L.K.
        • Kumpusalo E.
        • Tuomilehto J.
        • et al.
        The Metabolic Syndrome and total and cardiovascular disease mortality in middle-aged men.
        JAMA. 2002; 288: 2709-2716
        • Ridker P.M.
        • Buring J.E.
        • Cook N.R.
        • Rifai N.
        C-reactive protein, the Metabolic Syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women.
        Circulation. 2003; 107: 391-397
      1. Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–9.

      2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.

        • Hinsbergh V.W.M.
        Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation.
        Arterioscler Thromb. Vasc. Biol. 1997; 17: 1018-1023
        • De Caterina R.
        Endothelial dysfunctions: common denominators in vascular disease.
        Curr. Opin. Lipidol. 2000; 11: 9-23
        • Parving H.H.
        Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man-on the pathogenesis of hypertensive and diabetic microangiopathy.
        Dan. Med. Bull. 1975; 22: 217-233
        • Ginsberg H.N.
        Insulin resistance and cardiovascular disease.
        J. Clin. Invest. 2000; 106: 453-458
        • Furchgott R.F.
        • Zawadzki J.V.
        The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
        Nature. 1980; 288: 373-376
        • Nannipieri M.
        • Pilo A.
        • Rizzo L.
        • Penno G.
        • Rapuano A.
        • Navalesi R.
        Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients.
        Diabetes Care. 1995; 18: 1-9
        • Rosa U.
        • Pennisi F.
        • Bianchi R.
        • Federighi G.
        • Donato L.
        Chemical and biological effects of iodination on human albumin.
        Biochim. Biophys. Acta. 1967; 133: 486-498
        • Dell’Omo G.
        • Penno G.
        • Bandinelli S.
        • Pedrinelli R.
        • Mariani M.
        Simvastatin, capillary permeability and endothelial-mediated vasomotion in atherosclerotic, hypercholesterolemic men.
        Clin. Pharmacol. Ther. 2000; 68: 427-434
        • Bohme E.
        • Graf H.
        • Schultz G.
        Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP-formation in smooth muscle and platelets.
        Adv. Cyclic Nucleotide Res. 1978; 9: 131-143
        • Mather K.J.
        • Hunt A.E.
        • Steinberg H.O.
        • Paradisi G.
        • Hook G.
        • Katz A.
        • et al.
        Repeatability characteristics of simple indices of insulin resistance: implications for research applications.
        J. Clin. Endocrinol Metab. 2001; 86: 5457-5464
        • Pedrinelli R.
        • Penno G.
        • Dell’Omo G.
        • Bandinelli S.
        • Giorgi D.
        • Di Bello V.
        • et al.
        Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men.
        Hypertension. 1998; 32: 318-323
        • Prasad A.
        • Dunnil G.S.
        • Mac Gregor G.A.
        Capillary rarefaction in the forearm skin in essential hypertension.
        J. Hypertens. 1995; 13: 265-268
        • Parving H.H.
        • Gyntelberg F.
        Transcapillary escape rate of albumin and plasma volume in essential hypertension.
        Circ. Res. 1973; 32: 643-651
        • Pedrinelli R.
        • Penno G.
        • Dell’Omo G.
        • Bandinelli S.
        • Giorgi D.
        • Di Bello V.
        • et al.
        Microalbuminuria and transvascular albumin leakage in essential hypertension.
        Hypertension. 1999; 34: 491-495
        • Hilsted J.
        • Christensen N.J.
        Dual effect of insulin on plasma volume and transcapillary albumin transport.
        Diabetologia. 1992; 35: 99-103
        • Catalano C.
        • Muscelli E.
        • Quinones A.
        • Baldi S.
        • Masoni A.
        • Gibb I.
        • et al.
        Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.
        Diabetes. 1997; 46: 868-875
        • Sattar N.
        • Petrie J.R.
        • Jaap A.J.
        The atherogenic lipoprotein phenotype and vascular endothelial dysfunction.
        Atherosclerosis. 1998; 138: 229-235
        • Lum H.
        • Roebuck K.A.
        Oxidant stress and endothelial cell dysfunction.
        Am. J. Physiol. Cell. Physiol. 2001; 280: C719-C741
        • Perticone F.
        • Ceravolo R.
        • Pujia A.
        • Ventura G.
        • Iacopino S.
        • Scozzafava A.
        • et al.
        Prognostic significance of endothelial dysfunction in hypertensive patients.
        Circulation. 2001; 104: 191-196
        • Cockcroft J.R.
        • Chowienczyk P.J.
        • Benjamin N.
        • Ritter J.M.
        Preserved endothelium-dependent vasodilatation in patients with essential hypertension.
        N. Engl. J. Med. 1994; 330: 1036-1040
        • Stroes E.S.
        • Koomans H.A.
        • de Bruin T.W.
        • Rabelink T.J.
        Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.
        Lancet. 1995; 346: 467-471
        • Baron A.D.
        Insulin resistance and vascular function.
        J. Diabetes Complications. 2002; 16: 92-102
        • Natali A.
        • Taddei S.
        • Quinones Galvan A.
        • Camastra S.
        • Baldi S.
        • Frascerra S.
        • et al.
        Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension.
        Circulation. 1997; 96: 849-855
        • Steinberg H.O.
        • Chaker H.
        • Leaming R.
        • Johnson A.
        • Brechtel G.
        • Baron A.D.
        Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
        J. Clin. Invest. 1996; 97: 2601-2610
        • Lewis T.V.
        • Dart A.M.
        • Chin-Dusting J.P.
        Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol.
        J. Am. Coll. Cardiol. 1999; 33: 805-812
        • Lupattelli G.
        • Marchesi S.
        • Roscini A.R.
        • Siepi D.
        • Gemelli F.
        • Pirro M.
        • et al.
        Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia.
        Am. J. Cardiol. 2002; 90: 648-650
        • Spieker L.E.
        • Sudano I.
        • Hurlimann D.
        • Lerch P.G.
        • Lang M.G.
        • Binggeli C.
        • et al.
        High-density lipoprotein restores endothelial function in hypercholesterolemic men.
        Circulation. 2002; 105: 1399-1402
        • Angus J.A.
        • Lew M.J.
        Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension.
        J. Hypertens. Suppl. 1992; 10: s179-s186